Table 3.
Prevalence of people at risk of MDD, GAD, and both disorders by sex in the study sample
| |
Wave 1 n (%) |
Wave 2 n (%) |
Wave 3 n (%) |
Wave 4 n (%) |
All Waves n (%) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PHQ-9 (Cut-Off above 10) | Female | Male | Total | Female | Male | Total | Female | Male | Total | Female | Male | Total | Female | Male | Total |
| At risk of MDD | 321 (15.9) | 249 (12.5) | 570 (14.2) | 333 (15.9) | 225 (10.8) | 558 (13.3) | 351 (16.8) | 248 (12.1) | 599 (14.4) | 346 (16.6) | 213 (10.2) | 559 (13.4) | 1351 (16.3) | 935 (11.4) | 2286 (13.8) |
| Not at risk of MDD | 1694 (84.1) | 1740 (87.5) | 3434 (85.8) | 1764 (84.1) | 1858 (89.2) | 3622 (86.7) | 1744 (83.2) | 1810 (87.9) | 3554 85.6) | 1738 (83.4) | 1879 (89.8) | 3617 (86.6) | 6940 (83.7) | 7287 (88.6) | 14227 (86.2) |
| GAD-7 (Cut-Off above 10) | |||||||||||||||
| At risk of GAD | 269 (13.3) | 222 (11.2) | 419 (12.3) | 279 (13.3) | 184 (8.8) | 463 (11.1) | 281 (13.4) | 219 (10.6) | 500 (12.0) | 298 (14.3) | 191 (9.1) | 489 (11.7) | 1127 (13.6) | 816 (9.9) | 1943 (11.8) |
| Not at risk of GAD | 1746 (86.7) | 1767 (88.8) | 3513 (87.7) | 1818 (86.7) | 1899 (91.2) | 3717 (88.9) | 1814 (86.6) | 1839 (89.4) | 3653 (88.0) | 1786 (85.7) | 1901 (90.9) | 3687 (88.3) | 7164 (86.4) | 7406 (90.1) | 14570 (88.2) |
| Combined Risk of MDD and GAD | |||||||||||||||
| Yes | 260 (12.9) | 125 (6.3) | 290 (7.2) | 274 (13.1) | 107 (5.1) | 276 (6.6) | 268 (12.8) | 132 (6.4) | 314 (7.6) | 206 (9.9) | 117 (5.6) | 323 (7.7) | 722 (8.7) | 481 (5.9) | 1203 (7.3) |
| No | 1755 (87.1) | 1864 (93.7) | 3714 (92.8) | 1823 (86.9) | 1976 (94.9) | 3904 (93.4) | 1827 (87.2) | 1926 (93.6) | 3839 (92.4) | 1878 (90.1) | 1975 (94.4) | 3853 (92.3) | 7569 (91.3) | 7741 (94.1) | 15310 (92.7) |
| Grand Total | 2015 | 1989 | 4004 | 2097 | 2083 | 4180 | 2095 | 2058 | 4153 | 2084 | 2092 | 4176 | 8291 | 8222 | 16513 |